Literature DB >> 10931221

Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method.

N Patey-Mariaud De Serre1, C Cellier, B Jabri, E Delabesse, V Verkarre, B Roche, A Lavergne, J Brière, L Mauvieux, M Leborgne, J P Barbier, R Modigliani, C Matuchansky, E MacIntyre, N Cerf-Bensussan, N Brousse.   

Abstract

AIMS: We recently showed that refractory sprue is distinct from coeliac disease, the former being characterized by abnormal intraepithelial T-lymphocytes expressing a cytoplasmic CD3 chain (CD3c), lacking CD3 and CD8 surface expression, and showing TCRgamma gene rearrangements. To take advantage of the abnormal phenotype of CD3c + CD8 - intraepithelial lymphocytes (IEL) in refractory sprue we developed a simple method to distinguish coeliac disease from refractory sprue. METHODS AND
RESULTS: Comparative immunohistochemical studies using anti-CD3 and anti-CD8 antibodies were applied on paraffin-embedded and frozen biopsy specimens in refractory sprue (n = 6), coeliac disease (n = 10), healthy controls (n = 5) and suspected refractory sprue (n = 6). Comparable results were obtained on fixed and frozen biopsy specimens. In four of the six patients with suspected refractory sprue, abnormal CD3c + CD8 - IEL and TCRgamma gene rearrangements were found, as in refractory sprue; the remaining two patients had normal (CD3 + CD8 +) IEL and no TCRgamma gene rearrangements. Both patients had coeliac disease, as one failed to comply with a gluten-free diet, while the other was a slow responder.
CONCLUSION: This simplified immunostaining method using anti-CD3 and anti-CD8 antibodies on paraffin sections can distinguish active coeliac disease from refractory sprue and should prove useful in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10931221     DOI: 10.1046/j.1365-2559.2000.00926.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  25 in total

Review 1.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

Review 2.  Classification and management of refractory coeliac disease.

Authors:  Alberto Rubio-Tapia; Joseph A Murray
Journal:  Gut       Date:  2010-04       Impact factor: 23.059

3.  Severe spruelike enteropathy associated with olmesartan.

Authors:  Alberto Rubio-Tapia; Margot L Herman; Jonas F Ludvigsson; Darlene G Kelly; Thomas F Mangan; Tsung-Teh Wu; Joseph A Murray
Journal:  Mayo Clin Proc       Date:  2012-06-22       Impact factor: 7.616

Review 4.  Celiac disease: is the atypical really typical? Summary of the recent National Institutes of Health Consensus Conference and latest advances.

Authors:  Swati Gadewar; Alessio Fasano
Journal:  Curr Gastroenterol Rep       Date:  2005-12

Review 5.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

Review 6.  Celiac disease: pathogenesis of a model immunogenetic disease.

Authors:  Martin F Kagnoff
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

7.  Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease.

Authors:  R L J van Wanrooij; D M J Müller; E A Neefjes-Borst; J Meijer; L G Koudstaal; D A M Heideman; H J Bontkes; B M E von Blomberg; G Bouma; C J J Mulder
Journal:  J Clin Immunol       Date:  2014-07-27       Impact factor: 8.317

Review 8.  Celiac disease: prevalence, diagnosis, pathogenesis and treatment.

Authors:  Naiyana Gujral; Hugh J Freeman; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

9.  Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.

Authors:  A Al-Toma; W H M Verbeek; M Hadithi; B M E von Blomberg; C J J Mulder
Journal:  Gut       Date:  2007-04-30       Impact factor: 23.059

10.  Clinical staging and survival in refractory celiac disease: a single center experience.

Authors:  Alberto Rubio-Tapia; Darlene G Kelly; Brian D Lahr; Ahmet Dogan; Tsung-Teh Wu; Joseph A Murray
Journal:  Gastroenterology       Date:  2008-10-08       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.